Repligen (RGEN) EBIT Margin (2016 - 2025)
Historic EBIT Margin for Repligen (RGEN) over the last 16 years, with Q3 2025 value amounting to 8.91%.
- Repligen's EBIT Margin rose 139700.0% to 8.91% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.11%, marking a year-over-year decrease of 16600.0%. This contributed to the annual value of 5.53% for FY2024, which is 130800.0% down from last year.
- Per Repligen's latest filing, its EBIT Margin stood at 8.91% for Q3 2025, which was up 139700.0% from 7.62% recorded in Q2 2025.
- Repligen's EBIT Margin's 5-year high stood at 30.42% during Q2 2022, with a 5-year trough of 21.79% in Q4 2024.
- Over the past 5 years, Repligen's median EBIT Margin value was 8.91% (recorded in 2025), while the average stood at 12.72%.
- Per our database at Business Quant, Repligen's EBIT Margin tumbled by -277100bps in 2024 and then soared by 139700bps in 2025.
- Quarter analysis of 5 years shows Repligen's EBIT Margin stood at 20.07% in 2021, then soared by 30bps to 26.15% in 2022, then tumbled by -77bps to 5.93% in 2023, then plummeted by -468bps to 21.79% in 2024, then skyrocketed by 141bps to 8.91% in 2025.
- Its last three reported values are 8.91% in Q3 2025, 7.62% for Q2 2025, and 3.89% during Q1 2025.